

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 6.13502698 |
| 2 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 6.13502698 |
| 3 | modulation by symbiont of host immune response (GO:0052553) | 6.13502698 |
| 4 | positive regulation by symbiont of host defense response (GO:0052509) | 6.13502698 |
| 5 | modulation by symbiont of host defense response (GO:0052031) | 6.13502698 |
| 6 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 6.13502698 |
| 7 | regulation of interferon-beta biosynthetic process (GO:0045357) | 6.07480598 |
| 8 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.02230308 |
| 9 | macrophage activation involved in immune response (GO:0002281) | 4.59553047 |
| 10 | neutrophil activation involved in immune response (GO:0002283) | 4.46509830 |
| 11 | protein localization to endosome (GO:0036010) | 4.43953115 |
| 12 | positive regulation of mast cell activation (GO:0033005) | 4.16877206 |
| 13 | respiratory burst (GO:0045730) | 4.11580830 |
| 14 | positive regulation of interferon-alpha production (GO:0032727) | 4.09171013 |
| 15 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 4.02567087 |
| 16 | protein retention in ER lumen (GO:0006621) | 3.99125300 |
| 17 | immunoglobulin mediated immune response (GO:0016064) | 3.97422149 |
| 18 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.90996027 |
| 19 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.90606232 |
| 20 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.90606232 |
| 21 | mannose metabolic process (GO:0006013) | 3.88289885 |
| 22 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.87401038 |
| 23 | response to host immune response (GO:0052572) | 3.87401038 |
| 24 | regulation of interferon-alpha production (GO:0032647) | 3.85916556 |
| 25 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.83893919 |
| 26 | stress fiber assembly (GO:0043149) | 3.83642642 |
| 27 | skin morphogenesis (GO:0043589) | 3.81992911 |
| 28 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.70771539 |
| 29 | positive regulation of receptor recycling (GO:0001921) | 3.68513237 |
| 30 | apoptotic cell clearance (GO:0043277) | 3.67352168 |
| 31 | positive regulation of mast cell degranulation (GO:0043306) | 3.67246946 |
| 32 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.67246946 |
| 33 | microglial cell activation (GO:0001774) | 3.67031585 |
| 34 | response to host defenses (GO:0052200) | 3.61163349 |
| 35 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.61163349 |
| 36 | response to host (GO:0075136) | 3.61163349 |
| 37 | regulation of early endosome to late endosome transport (GO:2000641) | 3.58209317 |
| 38 | basement membrane organization (GO:0071711) | 3.57665344 |
| 39 | protein maturation by protein folding (GO:0022417) | 3.54953748 |
| 40 | positive regulation of leukocyte degranulation (GO:0043302) | 3.53412447 |
| 41 | negative regulation of granulocyte differentiation (GO:0030853) | 3.51165056 |
| 42 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.50371289 |
| 43 | regulation of mast cell degranulation (GO:0043304) | 3.44087431 |
| 44 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.37767822 |
| 45 | cell-substrate junction assembly (GO:0007044) | 3.34258955 |
| 46 | neutrophil mediated immunity (GO:0002446) | 3.33510954 |
| 47 | pinocytosis (GO:0006907) | 3.32993827 |
| 48 | regulation of superoxide anion generation (GO:0032928) | 3.29985446 |
| 49 | myeloid cell activation involved in immune response (GO:0002275) | 3.27141004 |
| 50 | pentose-phosphate shunt (GO:0006098) | 3.27081831 |
| 51 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.25873884 |
| 52 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.21137741 |
| 53 | regulation of cholesterol storage (GO:0010885) | 3.21122859 |
| 54 | positive regulation of antigen processing and presentation (GO:0002579) | 3.20673801 |
| 55 | response to peptidoglycan (GO:0032494) | 3.19078193 |
| 56 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.19025558 |
| 57 | adherens junction assembly (GO:0034333) | 3.18685649 |
| 58 | regulation of leukocyte degranulation (GO:0043300) | 3.17943214 |
| 59 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.16678260 |
| 60 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 3.15128013 |
| 61 | macrophage activation (GO:0042116) | 3.13870941 |
| 62 | proline biosynthetic process (GO:0006561) | 3.08958899 |
| 63 | regulation of mast cell activation (GO:0033003) | 3.07936316 |
| 64 | hyaluronan catabolic process (GO:0030214) | 3.03423883 |
| 65 | negative regulation of cell killing (GO:0031342) | 3.02300364 |
| 66 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.02300364 |
| 67 | cellular extravasation (GO:0045123) | 3.00998362 |
| 68 | keratan sulfate catabolic process (GO:0042340) | 3.00809274 |
| 69 | hemidesmosome assembly (GO:0031581) | 2.99655259 |
| 70 | positive regulation of B cell differentiation (GO:0045579) | 2.98570264 |
| 71 | regulation of macrophage chemotaxis (GO:0010758) | 2.97886253 |
| 72 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.97096224 |
| 73 | focal adhesion assembly (GO:0048041) | 2.92835476 |
| 74 | cell-substrate adherens junction assembly (GO:0007045) | 2.92835476 |
| 75 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.92834673 |
| 76 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.90389535 |
| 77 | response to laminar fluid shear stress (GO:0034616) | 2.89728721 |
| 78 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.89289985 |
| 79 | NADPH regeneration (GO:0006740) | 2.88845224 |
| 80 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.88576018 |
| 81 | glucose catabolic process (GO:0006007) | 2.88337433 |
| 82 | neutrophil activation (GO:0042119) | 2.87975400 |
| 83 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.85011838 |
| 84 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.84786648 |
| 85 | reactive oxygen species biosynthetic process (GO:1903409) | 2.82601536 |
| 86 | granulocyte activation (GO:0036230) | 2.82071990 |
| 87 | glucose 6-phosphate metabolic process (GO:0051156) | 2.80893211 |
| 88 | semaphorin-plexin signaling pathway (GO:0071526) | 2.80509627 |
| 89 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.79998359 |
| 90 | negative regulation of cell size (GO:0045792) | 2.79338999 |
| 91 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001241) | 2.79202327 |
| 92 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.78100486 |
| 93 | apoptotic process involved in morphogenesis (GO:0060561) | 2.77892392 |
| 94 | glycolipid catabolic process (GO:0019377) | 2.73173897 |
| 95 | positive regulation of interferon-beta production (GO:0032728) | 2.72630363 |
| 96 | B cell mediated immunity (GO:0019724) | 2.70005330 |
| 97 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.69791637 |
| 98 | low-density lipoprotein particle clearance (GO:0034383) | 2.69300464 |
| 99 | regulation of extracellular matrix disassembly (GO:0010715) | 2.69206704 |
| 100 | negative regulation of interleukin-6 production (GO:0032715) | 2.68516809 |
| 101 | platelet aggregation (GO:0070527) | 2.68153335 |
| 102 | actin nucleation (GO:0045010) | 2.67811859 |
| 103 | regulation of antigen processing and presentation (GO:0002577) | 2.67771767 |
| 104 | I-kappaB phosphorylation (GO:0007252) | 2.67601286 |
| 105 | negative regulation of stress fiber assembly (GO:0051497) | 2.65556198 |
| 106 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 2.63920466 |
| 107 | regulation of regulated secretory pathway (GO:1903305) | 2.63006872 |
| 108 | response to muramyl dipeptide (GO:0032495) | 2.62458890 |
| 109 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.61616703 |
| 110 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.61189352 |
| 111 | epithelial cell-cell adhesion (GO:0090136) | 2.60386051 |
| 112 | UV protection (GO:0009650) | 2.59172546 |
| 113 | membrane protein ectodomain proteolysis (GO:0006509) | 2.58427968 |
| 114 | regulation of phagocytosis (GO:0050764) | 2.58041108 |
| 115 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.58023534 |
| 116 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.57755191 |
| 117 | endodermal cell differentiation (GO:0035987) | 2.57566960 |
| 118 | cortical actin cytoskeleton organization (GO:0030866) | 2.56766074 |
| 119 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.56426703 |
| 120 | modulation by symbiont of host cellular process (GO:0044068) | 2.55227913 |
| 121 | regulation of mononuclear cell migration (GO:0071675) | 2.53636410 |
| 122 | positive regulation of phagocytosis (GO:0050766) | 2.52631281 |
| 123 | barbed-end actin filament capping (GO:0051016) | 2.51911822 |
| 124 | platelet degranulation (GO:0002576) | 2.50705007 |
| 125 | hypotonic response (GO:0006971) | 2.49925807 |
| 126 | negative regulation of phagocytosis (GO:0050765) | 2.49721279 |
| 127 | B cell receptor signaling pathway (GO:0050853) | 2.49606340 |
| 128 | fibril organization (GO:0097435) | 2.48287072 |
| 129 | positive regulation of nuclease activity (GO:0032075) | 2.46847530 |
| 130 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.46105153 |
| 131 | modulation by virus of host process (GO:0019054) | 2.45726726 |
| 132 | positive regulation of protein dephosphorylation (GO:0035307) | 2.45724060 |
| 133 | positive regulation of extracellular matrix organization (GO:1903055) | 2.45249921 |
| 134 | positive regulation of regulated secretory pathway (GO:1903307) | 2.45079187 |
| 135 | negative regulation of bone resorption (GO:0045779) | 2.44874415 |
| 136 | membrane raft organization (GO:0031579) | 2.44432199 |
| 137 | extracellular fibril organization (GO:0043206) | 2.44165845 |
| 138 | negative regulation of smooth muscle cell migration (GO:0014912) | 2.43998089 |
| 139 | cell adhesion mediated by integrin (GO:0033627) | 2.43691517 |
| 140 | response to fungus (GO:0009620) | 2.43689494 |
| 141 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.43626318 |
| 142 | myeloid leukocyte mediated immunity (GO:0002444) | 2.43623278 |
| 143 | COPI coating of Golgi vesicle (GO:0048205) | 2.43381224 |
| 144 | Golgi transport vesicle coating (GO:0048200) | 2.43381224 |
| 145 | regulation of B cell differentiation (GO:0045577) | 2.42956166 |
| 146 | amyloid precursor protein catabolic process (GO:0042987) | 2.42844436 |
| 147 | leukocyte aggregation (GO:0070486) | 2.41469709 |
| 148 | response to lipoprotein particle (GO:0055094) | 2.40047436 |
| 149 | neutrophil chemotaxis (GO:0030593) | 2.39912474 |
| 150 | regulation of integrin activation (GO:0033623) | 2.39591930 |
| 151 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 2.38875299 |
| 152 | angiogenesis involved in wound healing (GO:0060055) | 2.38315196 |
| 153 | phagocytosis (GO:0006909) | 2.37832021 |
| 154 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.37068570 |
| 155 | amino sugar catabolic process (GO:0046348) | 2.36994970 |
| 156 | actin filament polymerization (GO:0030041) | 2.36440957 |
| 157 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 2.35150024 |
| 158 | glycosphingolipid catabolic process (GO:0046479) | 2.34223296 |
| 159 | response to thyroid hormone (GO:0097066) | 2.34206226 |
| 160 | negative regulation of viral release from host cell (GO:1902187) | 2.33972115 |
| 161 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.31805538 |
| 162 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 2.31108212 |
| 163 | ceramide catabolic process (GO:0046514) | 2.30665257 |
| 164 | substrate-dependent cell migration (GO:0006929) | 2.29656040 |
| 165 | intracellular estrogen receptor signaling pathway (GO:0030520) | 2.29103463 |
| 166 | endoplasmic reticulum unfolded protein response (GO:0030968) | 2.28325721 |
| 167 | modulation by virus of host morphology or physiology (GO:0019048) | 2.27382462 |
| 168 | chondroitin sulfate biosynthetic process (GO:0030206) | 2.26040402 |
| 169 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.25405650 |
| 170 | cortical cytoskeleton organization (GO:0030865) | 2.25035176 |
| 171 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.24970914 |
| 172 | regulation of receptor recycling (GO:0001919) | 2.23347201 |
| 173 | negative regulation of fatty acid transport (GO:2000192) | 2.22525246 |
| 174 | regulation of defense response to virus by virus (GO:0050690) | 2.21577461 |
| 175 | cellular copper ion homeostasis (GO:0006878) | 2.20834898 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.38046198 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.93932487 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.82187785 |
| 4 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.50179106 |
| 5 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.45776964 |
| 6 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.19756227 |
| 7 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.15419341 |
| 8 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.13741782 |
| 9 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.10647893 |
| 10 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.96028975 |
| 11 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.92243970 |
| 12 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.84430862 |
| 13 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.75954214 |
| 14 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.75451051 |
| 15 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.43004508 |
| 16 | SPI1_23127762_ChIP-Seq_K562_Human | 2.35217048 |
| 17 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.33349769 |
| 18 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.24756868 |
| 19 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.18222701 |
| 20 | MYC_22102868_ChIP-Seq_BL_Human | 2.16886177 |
| 21 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.10746802 |
| 22 | * VDR_24763502_ChIP-Seq_THP-1_Human | 2.05531370 |
| 23 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.93681924 |
| 24 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.87729740 |
| 25 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.86552924 |
| 26 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.86538655 |
| 27 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.82906648 |
| 28 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.80972802 |
| 29 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.79656805 |
| 30 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.79362985 |
| 31 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.79001222 |
| 32 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.78647887 |
| 33 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.78509120 |
| 34 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.76715559 |
| 35 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.76613438 |
| 36 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.76549487 |
| 37 | MAF_26560356_Chip-Seq_TH1_Human | 1.76288898 |
| 38 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.75593464 |
| 39 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.74645443 |
| 40 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.71757451 |
| 41 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.67307407 |
| 42 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.65757881 |
| 43 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.64788555 |
| 44 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.64077482 |
| 45 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.64062134 |
| 46 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.61419707 |
| 47 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.60358452 |
| 48 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.60327320 |
| 49 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.57461501 |
| 50 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.57081331 |
| 51 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.56884513 |
| 52 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.55949294 |
| 53 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.55426203 |
| 54 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.54628294 |
| 55 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.54297974 |
| 56 | MYB_26560356_Chip-Seq_TH2_Human | 1.54235384 |
| 57 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.51447363 |
| 58 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.50314481 |
| 59 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.48822393 |
| 60 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.48399854 |
| 61 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.46316422 |
| 62 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.45237018 |
| 63 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.44954132 |
| 64 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.44370776 |
| 65 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.43786164 |
| 66 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.43649931 |
| 67 | GATA1_19941826_ChIP-Seq_K562_Human | 1.43415100 |
| 68 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.43232897 |
| 69 | UTX_26944678_Chip-Seq_JUKART_Human | 1.41728266 |
| 70 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.41644703 |
| 71 | GATA1_22025678_ChIP-Seq_K562_Human | 1.41508900 |
| 72 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.41385536 |
| 73 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.41017046 |
| 74 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.39305410 |
| 75 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.38093596 |
| 76 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.37478139 |
| 77 | KDM2B_26808549_Chip-Seq_K562_Human | 1.36785216 |
| 78 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.36168009 |
| 79 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.34308546 |
| 80 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.34184618 |
| 81 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.32104822 |
| 82 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.31859299 |
| 83 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.31618717 |
| 84 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.31437538 |
| 85 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.31334635 |
| 86 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.29942548 |
| 87 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.29716138 |
| 88 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.28949451 |
| 89 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.27980484 |
| 90 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.24786177 |
| 91 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.24568005 |
| 92 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.24254844 |
| 93 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.23668256 |
| 94 | ATF3_27146783_Chip-Seq_COLON_Human | 1.23645884 |
| 95 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.23012285 |
| 96 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.23012018 |
| 97 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.22710428 |
| 98 | P68_20966046_ChIP-Seq_HELA_Human | 1.22049140 |
| 99 | * MYB_26560356_Chip-Seq_TH1_Human | 1.21356339 |
| 100 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.20679538 |
| 101 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.19922027 |
| 102 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.19663147 |
| 103 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.19321283 |
| 104 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.18196154 |
| 105 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.17998688 |
| 106 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.17945236 |
| 107 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.17931362 |
| 108 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.17559883 |
| 109 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.16335527 |
| 110 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.16268818 |
| 111 | * CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.14924500 |
| 112 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.14764306 |
| 113 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.14269892 |
| 114 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.13735358 |
| 115 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.13733082 |
| 116 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.12691159 |
| 117 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.11036655 |
| 118 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.09767412 |
| 119 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.09499544 |
| 120 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.09319926 |
| 121 | GATA2_19941826_ChIP-Seq_K562_Human | 1.08788364 |
| 122 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.08614654 |
| 123 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.06775085 |
| 124 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.06682416 |
| 125 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.06173144 |
| 126 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.06020840 |
| 127 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.04017602 |
| 128 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.03231831 |
| 129 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.03159081 |
| 130 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.02437820 |
| 131 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.01822535 |
| 132 | MAF_26560356_Chip-Seq_TH2_Human | 1.01511310 |
| 133 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.01404267 |
| 134 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.00232742 |
| 135 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.00083500 |
| 136 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.99536713 |
| 137 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.99185018 |
| 138 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.99176188 |
| 139 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.99024604 |
| 140 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.98984417 |
| 141 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.98675517 |
| 142 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.97124197 |
| 143 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.97014904 |
| 144 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.96830626 |
| 145 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.92255546 |
| 146 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.90575368 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005058_abnormal_lysosome_morphology | 4.89583813 |
| 2 | MP0003172_abnormal_lysosome_physiology | 3.57139154 |
| 3 | MP0009840_abnormal_foam_cell | 3.48714160 |
| 4 | MP0003303_peritoneal_inflammation | 3.36588363 |
| 5 | MP0003436_decreased_susceptibility_to | 2.98209055 |
| 6 | MP0001835_abnormal_antigen_presentation | 2.73765211 |
| 7 | MP0003191_abnormal_cellular_cholesterol | 2.70642884 |
| 8 | MP0002419_abnormal_innate_immunity | 2.69324044 |
| 9 | MP0006082_CNS_inflammation | 2.59027906 |
| 10 | MP0008260_abnormal_autophagy | 2.58823986 |
| 11 | MP0003300_gastrointestinal_ulcer | 2.58336551 |
| 12 | MP0005451_abnormal_body_composition | 2.41913720 |
| 13 | MP0004272_abnormal_basement_membrane | 2.41179681 |
| 14 | MP0005464_abnormal_platelet_physiology | 2.19638162 |
| 15 | MP0003183_abnormal_peptide_metabolism | 2.19113076 |
| 16 | MP0001849_ear_inflammation | 2.14755574 |
| 17 | MP0004510_myositis | 2.13130152 |
| 18 | MP0005000_abnormal_immune_tolerance | 2.09773157 |
| 19 | MP0005387_immune_system_phenotype | 2.04581593 |
| 20 | MP0001790_abnormal_immune_system | 2.04581593 |
| 21 | MP0000604_amyloidosis | 2.02092932 |
| 22 | MP0001533_abnormal_skeleton_physiology | 1.99790386 |
| 23 | MP0005025_abnormal_response_to | 1.99472338 |
| 24 | MP0002452_abnormal_antigen_presenting | 1.98315441 |
| 25 | MP0000685_abnormal_immune_system | 1.96500271 |
| 26 | MP0002148_abnormal_hypersensitivity_rea | 1.89015863 |
| 27 | MP0003690_abnormal_glial_cell | 1.86978268 |
| 28 | MP0001800_abnormal_humoral_immune | 1.79591546 |
| 29 | MP0002723_abnormal_immune_serum | 1.78024886 |
| 30 | MP0000343_altered_response_to | 1.72343415 |
| 31 | MP0002420_abnormal_adaptive_immunity | 1.70452522 |
| 32 | MP0001819_abnormal_immune_cell | 1.70257490 |
| 33 | MP0003075_altered_response_to | 1.69287002 |
| 34 | MP0003566_abnormal_cell_adhesion | 1.66993494 |
| 35 | MP0009278_abnormal_bone_marrow | 1.66096341 |
| 36 | MP0004233_abnormal_muscle_weight | 1.62787772 |
| 37 | MP0008438_abnormal_cutaneous_collagen | 1.62659206 |
| 38 | MP0005671_abnormal_response_to | 1.62574387 |
| 39 | MP0003705_abnormal_hypodermis_morpholog | 1.60620777 |
| 40 | MP0002405_respiratory_system_inflammati | 1.58492538 |
| 41 | MP0005670_abnormal_white_adipose | 1.55481305 |
| 42 | MP0001845_abnormal_inflammatory_respons | 1.53984074 |
| 43 | MP0002998_abnormal_bone_remodeling | 1.53053759 |
| 44 | MP0009785_altered_susceptibility_to | 1.51281071 |
| 45 | MP0003279_aneurysm | 1.49992177 |
| 46 | MP0003724_increased_susceptibility_to | 1.49771917 |
| 47 | MP0001853_heart_inflammation | 1.46117274 |
| 48 | MP0010368_abnormal_lymphatic_system | 1.42270592 |
| 49 | MP0005257_abnormal_intraocular_pressure | 1.41838649 |
| 50 | MP0004947_skin_inflammation | 1.40193843 |
| 51 | MP0000569_abnormal_digit_pigmentation | 1.38970879 |
| 52 | MP0003448_altered_tumor_morphology | 1.38356361 |
| 53 | MP0008469_abnormal_protein_level | 1.37075813 |
| 54 | MP0002933_joint_inflammation | 1.35537798 |
| 55 | MP0003656_abnormal_erythrocyte_physiolo | 1.35222065 |
| 56 | MP0002060_abnormal_skin_morphology | 1.34787378 |
| 57 | MP0000858_altered_metastatic_potential | 1.34737960 |
| 58 | MP0000465_gastrointestinal_hemorrhage | 1.34323161 |
| 59 | MP0001851_eye_inflammation | 1.34035524 |
| 60 | MP0003453_abnormal_keratinocyte_physiol | 1.33099954 |
| 61 | MP0005310_abnormal_salivary_gland | 1.32122493 |
| 62 | MP0005409_darkened_coat_color | 1.30959100 |
| 63 | MP0009333_abnormal_splenocyte_physiolog | 1.29148593 |
| 64 | MP0002166_altered_tumor_susceptibility | 1.28777576 |
| 65 | MP0000716_abnormal_immune_system | 1.26672960 |
| 66 | MP0000689_abnormal_spleen_morphology | 1.22875423 |
| 67 | MP0005397_hematopoietic_system_phenotyp | 1.19343931 |
| 68 | MP0001545_abnormal_hematopoietic_system | 1.19343931 |
| 69 | MP0010030_abnormal_orbit_morphology | 1.17862193 |
| 70 | MP0002398_abnormal_bone_marrow | 1.16182871 |
| 71 | MP0000751_myopathy | 1.13734873 |
| 72 | MP0005623_abnormal_meninges_morphology | 1.13685857 |
| 73 | MP0002138_abnormal_hepatobiliary_system | 1.11768037 |
| 74 | MP0001958_emphysema | 1.11020720 |
| 75 | MP0005174_abnormal_tail_pigmentation | 1.08755195 |
| 76 | MP0010307_abnormal_tumor_latency | 1.08478349 |
| 77 | MP0005166_decreased_susceptibility_to | 1.07942296 |
| 78 | MP0002429_abnormal_blood_cell | 1.05972104 |
| 79 | MP0005621_abnormal_cell_physiology | 1.05357936 |
| 80 | MP0002396_abnormal_hematopoietic_system | 1.03504796 |
| 81 | MP0005076_abnormal_cell_differentiation | 1.03460765 |
| 82 | MP0004858_abnormal_nervous_system | 1.03119083 |
| 83 | MP0005501_abnormal_skin_physiology | 1.02437278 |
| 84 | MP0005390_skeleton_phenotype | 1.02298115 |
| 85 | MP0005083_abnormal_biliary_tract | 1.02217799 |
| 86 | MP0009384_cardiac_valve_regurgitation | 1.01972125 |
| 87 | MP0008004_abnormal_stomach_pH | 1.01738040 |
| 88 | MP0002722_abnormal_immune_system | 1.01065234 |
| 89 | MP0000609_abnormal_liver_physiology | 0.99986893 |
| 90 | MP0009764_decreased_sensitivity_to | 0.97832905 |
| 91 | MP0009053_abnormal_anal_canal | 0.97199681 |
| 92 | MP0004130_abnormal_muscle_cell | 0.96984684 |
| 93 | MP0005023_abnormal_wound_healing | 0.96914109 |
| 94 | MP0000678_abnormal_parathyroid_gland | 0.95174888 |
| 95 | MP0002254_reproductive_system_inflammat | 0.94106678 |
| 96 | MP0002896_abnormal_bone_mineralization | 0.92136610 |
| 97 | MP0006054_spinal_hemorrhage | 0.92032546 |
| 98 | MP0005167_abnormal_blood-brain_barrier | 0.91948304 |
| 99 | MP0003795_abnormal_bone_structure | 0.91380858 |
| 100 | MP0000249_abnormal_blood_vessel | 0.90835965 |
| 101 | MP0010155_abnormal_intestine_physiology | 0.90705109 |
| 102 | MP0000767_abnormal_smooth_muscle | 0.90085432 |
| 103 | MP0001542_abnormal_bone_strength | 0.89881936 |
| 104 | MP0001873_stomach_inflammation | 0.87055242 |
| 105 | MP0005508_abnormal_skeleton_morphology | 0.85579712 |
| 106 | MP0002796_impaired_skin_barrier | 0.85515838 |
| 107 | MP0003828_pulmonary_edema | 0.85276895 |
| 108 | MP0003091_abnormal_cell_migration | 0.84958458 |
| 109 | MP0002089_abnormal_postnatal_growth/wei | 0.84830965 |
| 110 | MP0002928_abnormal_bile_duct | 0.84325132 |
| 111 | MP0003252_abnormal_bile_duct | 0.83113701 |
| 112 | MP0000733_abnormal_muscle_development | 0.81287723 |
| 113 | MP0005165_increased_susceptibility_to | 0.81235777 |
| 114 | MP0010329_abnormal_lipoprotein_level | 0.79335115 |
| 115 | MP0001915_intracranial_hemorrhage | 0.78420782 |
| 116 | MP0004808_abnormal_hematopoietic_stem | 0.77859949 |
| 117 | MP0003329_amyloid_beta_deposits | 0.77763630 |
| 118 | MP0005666_abnormal_adipose_tissue | 0.77577767 |
| 119 | MP0002006_tumorigenesis | 0.77538901 |
| 120 | MP0010352_gastrointestinal_tract_polyps | 0.76594114 |
| 121 | MP0009763_increased_sensitivity_to | 0.76444424 |
| 122 | MP0001730_embryonic_growth_arrest | 0.75518470 |
| 123 | MP0000015_abnormal_ear_pigmentation | 0.75368371 |
| 124 | MP0000490_abnormal_crypts_of | 0.74233294 |
| 125 | MP0005384_cellular_phenotype | 0.73875789 |
| 126 | MP0004185_abnormal_adipocyte_glucose | 0.73047461 |
| 127 | MP0000598_abnormal_liver_morphology | 0.72967249 |
| 128 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.72053511 |
| 129 | MP0001614_abnormal_blood_vessel | 0.72001294 |
| 130 | MP0005319_abnormal_enzyme/_coenzyme | 0.71732270 |
| 131 | MP0005164_abnormal_response_to | 0.71700839 |
| 132 | MP0002877_abnormal_melanocyte_morpholog | 0.71495129 |
| 133 | MP0000759_abnormal_skeletal_muscle | 0.71435842 |
| 134 | MP0001216_abnormal_epidermal_layer | 0.71350511 |
| 135 | MP0000467_abnormal_esophagus_morphology | 0.68801830 |
| 136 | MP0009931_abnormal_skin_appearance | 0.68199281 |
| 137 | MP0002249_abnormal_larynx_morphology | 0.68117475 |
| 138 | MP0000681_abnormal_thyroid_gland | 0.67815238 |
| 139 | MP0005375_adipose_tissue_phenotype | 0.67429704 |
| 140 | MP0002113_abnormal_skeleton_development | 0.67272406 |
| 141 | MP0006138_congestive_heart_failure | 0.66937099 |
| 142 | MP0000003_abnormal_adipose_tissue | 0.63956812 |
| 143 | MP0004883_abnormal_blood_vessel | 0.63859851 |
| 144 | MP0004264_abnormal_extraembryonic_tissu | 0.63804546 |
| 145 | MP0001348_abnormal_lacrimal_gland | 0.62001873 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Increased cerebral lipofuscin (HP:0011813) | 6.29034365 |
| 2 | Recurrent abscess formation (HP:0002722) | 5.47203189 |
| 3 | Dysostosis multiplex (HP:0000943) | 5.42469629 |
| 4 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 5.39177164 |
| 5 | Vacuolated lymphocytes (HP:0001922) | 5.30439198 |
| 6 | Systemic lupus erythematosus (HP:0002725) | 5.13781538 |
| 7 | Eczematoid dermatitis (HP:0000976) | 5.07145524 |
| 8 | Recurrent bacterial skin infections (HP:0005406) | 5.05843386 |
| 9 | Mucopolysacchariduria (HP:0008155) | 4.73622036 |
| 10 | Urinary glycosaminoglycan excretion (HP:0003541) | 4.73622036 |
| 11 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.69375091 |
| 12 | Abnormality of glycolipid metabolism (HP:0010969) | 4.63405393 |
| 13 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.63405393 |
| 14 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.63405393 |
| 15 | Premature rupture of membranes (HP:0001788) | 4.55717447 |
| 16 | Abnormality of polysaccharide metabolism (HP:0011012) | 4.54423098 |
| 17 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 4.54423098 |
| 18 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 4.54423098 |
| 19 | Abnormality of macrophages (HP:0004311) | 4.19523546 |
| 20 | Protrusio acetabuli (HP:0003179) | 3.98973157 |
| 21 | Axonal loss (HP:0003447) | 3.72351474 |
| 22 | Glomerulonephritis (HP:0000099) | 3.46459004 |
| 23 | Disinhibition (HP:0000734) | 3.45122029 |
| 24 | Asymmetric septal hypertrophy (HP:0001670) | 3.44765729 |
| 25 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.33264686 |
| 26 | Loss of speech (HP:0002371) | 3.29147782 |
| 27 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 3.23837567 |
| 28 | Recurrent skin infections (HP:0001581) | 3.00781903 |
| 29 | Complement deficiency (HP:0004431) | 2.90223382 |
| 30 | Gingivitis (HP:0000230) | 2.86398426 |
| 31 | Ankle contracture (HP:0006466) | 2.83341888 |
| 32 | Cerebral aneurysm (HP:0004944) | 2.82672188 |
| 33 | Myocardial infarction (HP:0001658) | 2.78142365 |
| 34 | Ulnar bowing (HP:0003031) | 2.76757332 |
| 35 | Purpura (HP:0000979) | 2.76078596 |
| 36 | Hyperacusis (HP:0010780) | 2.75350217 |
| 37 | Abnormal platelet volume (HP:0011876) | 2.75178502 |
| 38 | Broad face (HP:0000283) | 2.73133172 |
| 39 | Spontaneous hematomas (HP:0007420) | 2.70123407 |
| 40 | Recurrent fungal infections (HP:0002841) | 2.68045818 |
| 41 | Increased mean platelet volume (HP:0011877) | 2.67086528 |
| 42 | Chronic obstructive pulmonary disease (HP:0006510) | 2.65671233 |
| 43 | Obstructive lung disease (HP:0006536) | 2.65671233 |
| 44 | Abnormality of complement system (HP:0005339) | 2.61341400 |
| 45 | Mediastinal lymphadenopathy (HP:0100721) | 2.61325483 |
| 46 | Myositis (HP:0100614) | 2.61243003 |
| 47 | Thoracic kyphosis (HP:0002942) | 2.59551093 |
| 48 | Menorrhagia (HP:0000132) | 2.57853308 |
| 49 | Distal lower limb muscle weakness (HP:0009053) | 2.56585822 |
| 50 | Achilles tendon contracture (HP:0001771) | 2.54552279 |
| 51 | Increased connective tissue (HP:0009025) | 2.53336834 |
| 52 | Blue sclerae (HP:0000592) | 2.50629926 |
| 53 | Atrophic scars (HP:0001075) | 2.50334862 |
| 54 | Distal lower limb amyotrophy (HP:0008944) | 2.47353075 |
| 55 | Abnormality of the Achilles tendon (HP:0005109) | 2.46434674 |
| 56 | Distal upper limb amyotrophy (HP:0007149) | 2.45970923 |
| 57 | Upper limb amyotrophy (HP:0009129) | 2.45970923 |
| 58 | Cellulitis (HP:0100658) | 2.45658024 |
| 59 | Agnosia (HP:0010524) | 2.44370297 |
| 60 | Spinal rigidity (HP:0003306) | 2.43676596 |
| 61 | Retinal atrophy (HP:0001105) | 2.43460261 |
| 62 | Spondylolisthesis (HP:0003302) | 2.41742999 |
| 63 | Neuronal loss in central nervous system (HP:0002529) | 2.40380818 |
| 64 | Fragile skin (HP:0001030) | 2.39290455 |
| 65 | Short nail (HP:0001799) | 2.37250248 |
| 66 | Autoimmune thrombocytopenia (HP:0001973) | 2.36760463 |
| 67 | Hematochezia (HP:0002573) | 2.36750693 |
| 68 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.29639998 |
| 69 | Stomatitis (HP:0010280) | 2.29135479 |
| 70 | Shallow orbits (HP:0000586) | 2.29053321 |
| 71 | Mitral stenosis (HP:0001718) | 2.27525731 |
| 72 | Urticaria (HP:0001025) | 2.27403433 |
| 73 | J-shaped sella turcica (HP:0002680) | 2.27343147 |
| 74 | Progressive neurologic deterioration (HP:0002344) | 2.26768123 |
| 75 | Upper motor neuron abnormality (HP:0002127) | 2.26262212 |
| 76 | Genu recurvatum (HP:0002816) | 2.26090658 |
| 77 | Vascular tortuosity (HP:0004948) | 2.25373699 |
| 78 | Joint stiffness (HP:0001387) | 2.24075520 |
| 79 | Diminished motivation (HP:0000745) | 2.23433980 |
| 80 | Neurofibrillary tangles (HP:0002185) | 2.23237639 |
| 81 | Nephritis (HP:0000123) | 2.22882114 |
| 82 | Apathy (HP:0000741) | 2.22850500 |
| 83 | Arterial tortuosity (HP:0005116) | 2.22757327 |
| 84 | Wormian bones (HP:0002645) | 2.22084039 |
| 85 | Increased variability in muscle fiber diameter (HP:0003557) | 2.21543312 |
| 86 | Mutism (HP:0002300) | 2.21201042 |
| 87 | Pathologic fracture (HP:0002756) | 2.20790482 |
| 88 | Abnormality of the lumbar spine (HP:0100712) | 2.20639491 |
| 89 | Ovoid vertebral bodies (HP:0003300) | 2.18505108 |
| 90 | Recurrent viral infections (HP:0004429) | 2.17698137 |
| 91 | Interstitial pulmonary disease (HP:0006530) | 2.17254535 |
| 92 | Cervical subluxation (HP:0003308) | 2.14918978 |
| 93 | Supranuclear gaze palsy (HP:0000605) | 2.13711283 |
| 94 | Global brain atrophy (HP:0002283) | 2.12714211 |
| 95 | Prolonged bleeding time (HP:0003010) | 2.11898153 |
| 96 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.11378349 |
| 97 | Hepatosplenomegaly (HP:0001433) | 2.09167655 |
| 98 | Vertebral compression fractures (HP:0002953) | 2.08584803 |
| 99 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.08147719 |
| 100 | Dilatation of the ascending aorta (HP:0005111) | 2.06998342 |
| 101 | Mitral regurgitation (HP:0001653) | 2.03976305 |
| 102 | Abnormality of the thoracic spine (HP:0100711) | 2.02905124 |
| 103 | Generalized amyotrophy (HP:0003700) | 2.02815041 |
| 104 | Orchitis (HP:0100796) | 2.00221625 |
| 105 | Elbow flexion contracture (HP:0002987) | 1.99842718 |
| 106 | Progressive visual loss (HP:0000529) | 1.99084577 |
| 107 | Pustule (HP:0200039) | 1.98263198 |
| 108 | Periodontitis (HP:0000704) | 1.94855189 |
| 109 | Cardiomegaly (HP:0001640) | 1.94380016 |
| 110 | Slow saccadic eye movements (HP:0000514) | 1.94332100 |
| 111 | Gingival bleeding (HP:0000225) | 1.93794102 |
| 112 | Impaired platelet aggregation (HP:0003540) | 1.92949025 |
| 113 | Abnormal platelet function (HP:0011869) | 1.92949025 |
| 114 | Aortic dissection (HP:0002647) | 1.91579987 |
| 115 | Hemorrhage of the eye (HP:0011885) | 1.91260635 |
| 116 | Petechiae (HP:0000967) | 1.91001559 |
| 117 | Basal ganglia calcification (HP:0002135) | 1.90754548 |
| 118 | Epistaxis (HP:0000421) | 1.90218979 |
| 119 | Slender build (HP:0001533) | 1.88838854 |
| 120 | Inflammation of the large intestine (HP:0002037) | 1.88580634 |
| 121 | Gastrointestinal inflammation (HP:0004386) | 1.87539969 |
| 122 | Aneurysm (HP:0002617) | 1.86829071 |
| 123 | Back pain (HP:0003418) | 1.85980816 |
| 124 | Bladder diverticulum (HP:0000015) | 1.85775745 |
| 125 | Osteomyelitis (HP:0002754) | 1.85672014 |
| 126 | Tetraparesis (HP:0002273) | 1.84774339 |
| 127 | Difficulty climbing stairs (HP:0003551) | 1.82776592 |
| 128 | Joint laxity (HP:0001388) | 1.82506003 |
| 129 | Abnormality of the acetabulum (HP:0003170) | 1.82457459 |
| 130 | Biconcave vertebral bodies (HP:0004586) | 1.82107135 |
| 131 | Abnormal ossification of hand bones (HP:0005921) | 1.81466176 |
| 132 | Disproportionate tall stature (HP:0001519) | 1.81354491 |
| 133 | Peripheral demyelination (HP:0011096) | 1.81260510 |
| 134 | Abnormality of dentin (HP:0010299) | 1.80663184 |
| 135 | Amyloidosis (HP:0011034) | 1.79894479 |
| 136 | Chronic otitis media (HP:0000389) | 1.79469851 |
| 137 | Long palpebral fissure (HP:0000637) | 1.79055505 |
| 138 | Flat acetabular roof (HP:0003180) | 1.78905410 |
| 139 | Abnormality of the nasal mucosa (HP:0000433) | 1.78782357 |
| 140 | Increased CSF protein (HP:0002922) | 1.78389256 |
| 141 | Personality changes (HP:0000751) | 1.78000751 |
| 142 | Cerebral inclusion bodies (HP:0100314) | 1.77678799 |
| 143 | Aortic aneurysm (HP:0004942) | 1.77039066 |
| 144 | Deep venous thrombosis (HP:0002625) | 1.76796451 |
| 145 | Deformed sella turcica (HP:0002681) | 1.76718133 |
| 146 | Hand muscle atrophy (HP:0009130) | 1.75193477 |
| 147 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.73903316 |
| 148 | Mitral valve prolapse (HP:0001634) | 1.73521893 |
| 149 | Obstructive sleep apnea (HP:0002870) | 1.72460747 |
| 150 | Natal tooth (HP:0000695) | 1.72193476 |
| 151 | Nasal polyposis (HP:0100582) | 1.72145378 |
| 152 | Nonimmune hydrops fetalis (HP:0001790) | 1.71684773 |
| 153 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.71511760 |
| 154 | Osteolytic defects of the hand bones (HP:0009699) | 1.71511760 |
| 155 | Hypertriglyceridemia (HP:0002155) | 1.71026176 |
| 156 | Peritonitis (HP:0002586) | 1.70213693 |
| 157 | Striae distensae (HP:0001065) | 1.70155930 |
| 158 | Polygenic inheritance (HP:0010982) | 1.67936613 |
| 159 | Bone pain (HP:0002653) | 1.66609621 |
| 160 | Lower limb amyotrophy (HP:0007210) | 1.66391106 |
| 161 | Abnormality of carpal bone ossification (HP:0006257) | 1.65518832 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 4.44200830 |
| 2 | TRIB3 | 3.80315737 |
| 3 | PRPF4B | 3.14735037 |
| 4 | ICK | 3.14406549 |
| 5 | TGFBR2 | 3.01394547 |
| 6 | SMG1 | 2.75012050 |
| 7 | MAP4K1 | 2.61400512 |
| 8 | TBK1 | 2.52785839 |
| 9 | KIT | 2.50236712 |
| 10 | PKN2 | 2.33017180 |
| 11 | TYK2 | 2.29367018 |
| 12 | TAOK3 | 2.28012992 |
| 13 | BLK | 2.26822068 |
| 14 | CAMK1D | 2.14666470 |
| 15 | TESK1 | 2.14445214 |
| 16 | ZAP70 | 2.08245328 |
| 17 | EPHB1 | 1.97711636 |
| 18 | IRAK3 | 1.87404047 |
| 19 | TAOK2 | 1.82024768 |
| 20 | RIPK4 | 1.65379611 |
| 21 | CAMK1G | 1.63495870 |
| 22 | CSF1R | 1.59512739 |
| 23 | JAK3 | 1.54977923 |
| 24 | TTN | 1.54802146 |
| 25 | PRKD2 | 1.54235605 |
| 26 | SCYL2 | 1.51641744 |
| 27 | JAK1 | 1.50365804 |
| 28 | STK10 | 1.49682115 |
| 29 | EPHA2 | 1.40113256 |
| 30 | FES | 1.37367598 |
| 31 | IRAK4 | 1.33748260 |
| 32 | EEF2K | 1.31666790 |
| 33 | MAP2K3 | 1.30662666 |
| 34 | HCK | 1.30616761 |
| 35 | ARAF | 1.26968568 |
| 36 | SIK3 | 1.26910184 |
| 37 | SIK1 | 1.26909679 |
| 38 | PTK6 | 1.24560810 |
| 39 | RIPK1 | 1.23960450 |
| 40 | CDC42BPA | 1.21826828 |
| 41 | IKBKE | 1.21758110 |
| 42 | PIM2 | 1.20298020 |
| 43 | NEK9 | 1.18984718 |
| 44 | CSK | 1.16800345 |
| 45 | KDR | 1.16549089 |
| 46 | JAK2 | 1.15701571 |
| 47 | BTK | 1.15560519 |
| 48 | MAP3K14 | 1.14499293 |
| 49 | CAMKK2 | 1.08454191 |
| 50 | SYK | 1.08390878 |
| 51 | PAK4 | 1.03320809 |
| 52 | GRK6 | 1.03225029 |
| 53 | LRRK2 | 1.01504074 |
| 54 | LIMK1 | 1.01121681 |
| 55 | CDK12 | 1.00218836 |
| 56 | MAP3K13 | 1.00139355 |
| 57 | NTRK1 | 0.99113165 |
| 58 | TXK | 0.98573951 |
| 59 | MAP3K11 | 0.97856703 |
| 60 | IKBKB | 0.93531252 |
| 61 | MARK2 | 0.93209159 |
| 62 | TRPM7 | 0.90263054 |
| 63 | MATK | 0.89968308 |
| 64 | CAMKK1 | 0.89210726 |
| 65 | MAP3K1 | 0.85695052 |
| 66 | NME2 | 0.85576494 |
| 67 | LCK | 0.85500157 |
| 68 | EPHB2 | 0.84563914 |
| 69 | MARK3 | 0.84314991 |
| 70 | ITK | 0.83908142 |
| 71 | MST1R | 0.83064573 |
| 72 | LYN | 0.82409993 |
| 73 | PRKD3 | 0.80297954 |
| 74 | RPS6KA4 | 0.80105477 |
| 75 | EPHA3 | 0.77814864 |
| 76 | DDR2 | 0.77554829 |
| 77 | BMX | 0.76713919 |
| 78 | GRK7 | 0.75962921 |
| 79 | PRKCH | 0.75591874 |
| 80 | FLT3 | 0.75571167 |
| 81 | TESK2 | 0.74278043 |
| 82 | MAP3K6 | 0.74110450 |
| 83 | CDK7 | 0.73167522 |
| 84 | DMPK | 0.73024922 |
| 85 | MAP3K10 | 0.70703175 |
| 86 | TAOK1 | 0.70609601 |
| 87 | RPS6KA2 | 0.69579191 |
| 88 | SIK2 | 0.69225220 |
| 89 | EGFR | 0.69091029 |
| 90 | RPS6KA6 | 0.61876712 |
| 91 | FGR | 0.61447730 |
| 92 | KSR2 | 0.61398742 |
| 93 | TEC | 0.61044003 |
| 94 | FGFR4 | 0.60978204 |
| 95 | MAP3K3 | 0.58809785 |
| 96 | MYLK | 0.58288217 |
| 97 | PRKG2 | 0.57479467 |
| 98 | STK38 | 0.56647580 |
| 99 | CLK1 | 0.55868810 |
| 100 | MAP3K8 | 0.54836317 |
| 101 | RPS6KC1 | 0.54182174 |
| 102 | RPS6KL1 | 0.54182174 |
| 103 | MAPK12 | 0.54150426 |
| 104 | DYRK1B | 0.54032625 |
| 105 | MOS | 0.53932756 |
| 106 | PAK1 | 0.53853030 |
| 107 | LATS2 | 0.53687423 |
| 108 | ILK | 0.53135088 |
| 109 | BCKDK | 0.52990741 |
| 110 | PTK2B | 0.52976116 |
| 111 | IRAK2 | 0.52038426 |
| 112 | MAPK11 | 0.51988512 |
| 113 | PDPK1 | 0.51954403 |
| 114 | CDK4 | 0.51948662 |
| 115 | MAPK15 | 0.51906673 |
| 116 | MAP2K2 | 0.51087494 |
| 117 | CHUK | 0.51033291 |
| 118 | BRAF | 0.50170649 |
| 119 | LMTK2 | 0.50150482 |
| 120 | PTK2 | 0.49564891 |
| 121 | PIM1 | 0.48205711 |
| 122 | PRKCD | 0.47827017 |
| 123 | CDK6 | 0.47698514 |
| 124 | PDGFRA | 0.47680436 |
| 125 | PDGFRB | 0.47566528 |
| 126 | PAK2 | 0.47555319 |
| 127 | HIPK2 | 0.46897535 |
| 128 | PRKD1 | 0.46220553 |
| 129 | MAPKAPK2 | 0.46038769 |
| 130 | RET | 0.45655923 |
| 131 | MTOR | 0.44861447 |
| 132 | ABL2 | 0.44768040 |
| 133 | MAPK7 | 0.44044766 |
| 134 | CDK9 | 0.41711974 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 4.35884618 |
| 2 | Lysosome_Homo sapiens_hsa04142 | 3.83564669 |
| 3 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.63834121 |
| 4 | Other glycan degradation_Homo sapiens_hsa00511 | 3.53577383 |
| 5 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.54216575 |
| 6 | Leishmaniasis_Homo sapiens_hsa05140 | 2.47742876 |
| 7 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 2.17450865 |
| 8 | Tuberculosis_Homo sapiens_hsa05152 | 1.93993107 |
| 9 | Bladder cancer_Homo sapiens_hsa05219 | 1.91409417 |
| 10 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.84315121 |
| 11 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.80752617 |
| 12 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.79384486 |
| 13 | Pertussis_Homo sapiens_hsa05133 | 1.75417637 |
| 14 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.68000842 |
| 15 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.62973213 |
| 16 | Phagosome_Homo sapiens_hsa04145 | 1.61266641 |
| 17 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.55822378 |
| 18 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.48107884 |
| 19 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.46290290 |
| 20 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.41816926 |
| 21 | Malaria_Homo sapiens_hsa05144 | 1.34631393 |
| 22 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.33762446 |
| 23 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.33151828 |
| 24 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.32689781 |
| 25 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.27316082 |
| 26 | Legionellosis_Homo sapiens_hsa05134 | 1.25972699 |
| 27 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.25106072 |
| 28 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.23959441 |
| 29 | Endometrial cancer_Homo sapiens_hsa05213 | 1.20923390 |
| 30 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.20778827 |
| 31 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.20668396 |
| 32 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.19555702 |
| 33 | Shigellosis_Homo sapiens_hsa05131 | 1.18950780 |
| 34 | Apoptosis_Homo sapiens_hsa04210 | 1.18473127 |
| 35 | Thyroid cancer_Homo sapiens_hsa05216 | 1.17634743 |
| 36 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.14401684 |
| 37 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.13364903 |
| 38 | Salmonella infection_Homo sapiens_hsa05132 | 1.13012280 |
| 39 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.06960644 |
| 40 | Measles_Homo sapiens_hsa05162 | 1.06529346 |
| 41 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.02407711 |
| 42 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.00549453 |
| 43 | Prostate cancer_Homo sapiens_hsa05215 | 0.98924662 |
| 44 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.98865697 |
| 45 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.98361730 |
| 46 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.97545589 |
| 47 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.97351562 |
| 48 | Adherens junction_Homo sapiens_hsa04520 | 0.96377120 |
| 49 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.95228745 |
| 50 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.94785616 |
| 51 | Influenza A_Homo sapiens_hsa05164 | 0.93890035 |
| 52 | Prion diseases_Homo sapiens_hsa05020 | 0.92701781 |
| 53 | Amoebiasis_Homo sapiens_hsa05146 | 0.92076848 |
| 54 | Sulfur relay system_Homo sapiens_hsa04122 | 0.91485927 |
| 55 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.91016155 |
| 56 | Platelet activation_Homo sapiens_hsa04611 | 0.90252453 |
| 57 | Hepatitis B_Homo sapiens_hsa05161 | 0.89800540 |
| 58 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.89588821 |
| 59 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.89159620 |
| 60 | Endocytosis_Homo sapiens_hsa04144 | 0.87053496 |
| 61 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.86005214 |
| 62 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.84466371 |
| 63 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.84005556 |
| 64 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.80343434 |
| 65 | Asthma_Homo sapiens_hsa05310 | 0.77935007 |
| 66 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.77100758 |
| 67 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.76414636 |
| 68 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.76369953 |
| 69 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.76191926 |
| 70 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.75245395 |
| 71 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.73500873 |
| 72 | Insulin resistance_Homo sapiens_hsa04931 | 0.71542847 |
| 73 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.71455273 |
| 74 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.70799312 |
| 75 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.70602030 |
| 76 | Viral myocarditis_Homo sapiens_hsa05416 | 0.70078660 |
| 77 | Galactose metabolism_Homo sapiens_hsa00052 | 0.69790016 |
| 78 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.68364574 |
| 79 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.68048148 |
| 80 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.65940910 |
| 81 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.64674190 |
| 82 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.64448733 |
| 83 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.63539584 |
| 84 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.59608920 |
| 85 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.59555678 |
| 86 | HTLV-I infection_Homo sapiens_hsa05166 | 0.58922571 |
| 87 | Pathways in cancer_Homo sapiens_hsa05200 | 0.58801656 |
| 88 | Hepatitis C_Homo sapiens_hsa05160 | 0.58229079 |
| 89 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.58187616 |
| 90 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.57131206 |
| 91 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.55939204 |
| 92 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.55863726 |
| 93 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.55577977 |
| 94 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.54527326 |
| 95 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.54291644 |
| 96 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.54114833 |
| 97 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.53999590 |
| 98 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.53327659 |
| 99 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.53178503 |
| 100 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.52141060 |
| 101 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.50156142 |
| 102 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.48888487 |
| 103 | ABC transporters_Homo sapiens_hsa02010 | 0.48880931 |
| 104 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.48573386 |
| 105 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.48486681 |
| 106 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.48424782 |
| 107 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.47794441 |
| 108 | Melanoma_Homo sapiens_hsa05218 | 0.47533359 |
| 109 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.46911836 |
| 110 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.46908213 |
| 111 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.44889943 |
| 112 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.44742658 |
| 113 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.44673059 |
| 114 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.44633509 |
| 115 | Focal adhesion_Homo sapiens_hsa04510 | 0.44282886 |
| 116 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.43087369 |
| 117 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.42380007 |
| 118 | Lysine degradation_Homo sapiens_hsa00310 | 0.41829381 |
| 119 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.41329398 |
| 120 | Colorectal cancer_Homo sapiens_hsa05210 | 0.40884370 |
| 121 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.40416225 |
| 122 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.40269108 |
| 123 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.34993970 |
| 124 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.34518955 |
| 125 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.34053907 |
| 126 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.33696727 |
| 127 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.33059612 |
| 128 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.32573734 |
| 129 | Bile secretion_Homo sapiens_hsa04976 | 0.32182667 |
| 130 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.31321006 |
| 131 | Glioma_Homo sapiens_hsa05214 | 0.28202466 |

